Cargando…
D-Penicillamine-Induced Myasthenia Gravis—A Probable Complication of Wilson’s Disease Treatment—A Case Report and Systematic Review of the Literature
Wilson’s disease (WD) is a genetic disorder with copper accumulation in various tissues leading to related clinical symptoms (mainly hepatic and neuropsychiatric) which can be in 85% of patients successfully treated with anti-copper agents. However, during WD treatment neurological deterioration may...
Autores principales: | Antos, Agnieszka, Członkowska, Anna, Bembenek, Jan, Kurkowska-Jastrzębska, Iwona, Litwin, Tomasz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10455431/ https://www.ncbi.nlm.nih.gov/pubmed/37629572 http://dx.doi.org/10.3390/life13081715 |
Ejemplares similares
-
Blood Based Biomarkers of Central Nervous System Involvement in Wilson’s Disease
por: Antos, Agnieszka, et al.
Publicado: (2023) -
Liver transplantation as a treatment for Wilson’s disease with neurological presentation: a systematic literature review
por: Litwin, Tomasz, et al.
Publicado: (2022) -
Copper Deficiency as Wilson’s Disease Overtreatment: A Systematic Review
por: Litwin, Tomasz, et al.
Publicado: (2023) -
Early neurological deterioration in Wilson’s disease: a systematic literature review and meta-analysis
por: Antos, Agnieszka, et al.
Publicado: (2023) -
The Maternal and Fetal Outcomes of Pregnancy in Wilson’s Disease: A Systematic Literature Review and Meta-Analysis
por: Litwin, Tomasz, et al.
Publicado: (2022)